ID22543A - Senyawa karbapenem, penggunaan dan senyawa antaranya - Google Patents

Senyawa karbapenem, penggunaan dan senyawa antaranya

Info

Publication number
ID22543A
ID22543A IDW990915A ID990915A ID22543A ID 22543 A ID22543 A ID 22543A ID W990915 A IDW990915 A ID W990915A ID 990915 A ID990915 A ID 990915A ID 22543 A ID22543 A ID 22543A
Authority
ID
Indonesia
Prior art keywords
diseases
infectious diseases
prophylaxis
agents
treatment
Prior art date
Application number
IDW990915A
Other languages
English (en)
Indonesian (id)
Inventor
Hiroshi Matsui
Masayasu Kasai
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of ID22543A publication Critical patent/ID22543A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW990915A 1997-02-07 1998-02-02 Senyawa karbapenem, penggunaan dan senyawa antaranya ID22543A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2567197 1997-02-07
JP24890397 1997-09-12

Publications (1)

Publication Number Publication Date
ID22543A true ID22543A (id) 1999-11-04

Family

ID=26363329

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990915A ID22543A (id) 1997-02-07 1998-02-02 Senyawa karbapenem, penggunaan dan senyawa antaranya

Country Status (24)

Country Link
US (1) US6342494B1 (fr)
EP (1) EP0987267B1 (fr)
KR (1) KR100530478B1 (fr)
CN (1) CN1107067C (fr)
AT (1) ATE239728T1 (fr)
AU (1) AU740327C (fr)
BG (1) BG63974B1 (fr)
BR (1) BR9807187A (fr)
CA (1) CA2280273A1 (fr)
CZ (1) CZ272099A3 (fr)
DE (1) DE69814381T2 (fr)
ES (1) ES2198689T3 (fr)
HK (1) HK1026896A1 (fr)
HU (1) HUP0000952A3 (fr)
ID (1) ID22543A (fr)
NO (1) NO993774L (fr)
NZ (1) NZ337532A (fr)
PL (1) PL335048A1 (fr)
RU (1) RU2178792C2 (fr)
SK (1) SK108099A3 (fr)
TR (1) TR199901887T2 (fr)
TW (1) TW580499B (fr)
WO (1) WO1998034936A1 (fr)
YU (1) YU37299A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040176350A1 (en) * 2001-05-21 2004-09-09 Hiroshi Matsui Carbapenem compound
US7205291B2 (en) * 2001-11-05 2007-04-17 Dainippon Sumitomo Pharma Co., Ltd. Carbapenem compounds
US7468364B2 (en) * 2003-04-08 2008-12-23 Dainippon Sumitomo Pharma Co., Ltd. Carbapenem compounds
EP1785426A4 (fr) * 2004-09-03 2008-02-20 Dainippon Sumitomo Pharma Co Nouveau dérivé de carbapénème
US20090029964A1 (en) * 2005-03-25 2009-01-29 Makoto Sunagawa Novel carbapenem compound
KR100869165B1 (ko) 2007-09-13 2008-11-19 조동옥 메로페넴의 개선된 제조방법
CN101868460A (zh) * 2007-11-23 2010-10-20 国际药品工业株式会社 2-芳基甲基吖丁啶-碳青霉烯-3-羧酸酯衍生物或其盐、其制备方法以及包含上述的药物组合物
CN103504481A (zh) * 2013-10-11 2014-01-15 红塔烟草(集团)有限责任公司 一种带抗菌层烟嘴的电子卷烟

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (fr) * 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
US5360798A (en) * 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
NZ324447A (en) 1995-12-21 1999-08-30 Sankyo Co 1-methyl-carbapenem substituted by a 4-pyrrolidinylthio group and medicaments
JP3671529B2 (ja) 1996-07-29 2005-07-13 ソニー株式会社 熱転写形記録装置及び記録方法

Also Published As

Publication number Publication date
KR20000070809A (ko) 2000-11-25
EP0987267A1 (fr) 2000-03-22
BG63974B1 (bg) 2003-08-29
AU740327C (en) 2002-05-09
HUP0000952A3 (en) 2000-12-28
DE69814381T2 (de) 2003-12-04
ES2198689T3 (es) 2004-02-01
HUP0000952A2 (hu) 2000-10-28
YU37299A (sh) 2002-06-19
US6342494B1 (en) 2002-01-29
EP0987267A4 (fr) 2000-05-31
ATE239728T1 (de) 2003-05-15
AU5680698A (en) 1998-08-26
CZ272099A3 (cs) 1999-11-17
NZ337532A (en) 2001-06-29
KR100530478B1 (ko) 2005-11-23
HK1026896A1 (en) 2000-12-29
TR199901887T2 (xx) 1999-12-21
BR9807187A (pt) 2000-01-25
CA2280273A1 (fr) 1998-08-13
NO993774L (no) 1999-09-30
WO1998034936A1 (fr) 1998-08-13
CN1107067C (zh) 2003-04-30
AU740327B2 (en) 2001-11-01
DE69814381D1 (de) 2003-06-12
PL335048A1 (en) 2000-03-27
NO993774D0 (no) 1999-08-04
CN1252072A (zh) 2000-05-03
SK108099A3 (en) 2000-03-13
RU2178792C2 (ru) 2002-01-27
TW580499B (en) 2004-03-21
BG103699A (en) 2000-06-30
EP0987267B1 (fr) 2003-05-07

Similar Documents

Publication Publication Date Title
DE60004803D1 (de) Pulmonare abgabe von protonierter/angesäuerter nukleinsäure
AR037595A1 (es) Metodos de tratamiento y formulaciones de cefalosporina
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
PT1235826E (pt) Acrilamidas de quinuclidina
ATE319710T1 (de) Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
CY1111951T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
NO20081005L (no) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
ID22543A (id) Senyawa karbapenem, penggunaan dan senyawa antaranya
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BR9910098A (pt) Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos
CA2386685A1 (fr) Utilisation de derives de pleuromutiline pour le traitement transdermique de maladies bacteriennes
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
ATE163294T1 (de) Die antibiotika ge 37468 a, b und c
TH36001A (th) สารประกอบคาร์บาเพเนม การใช้ประโยชน์ของมัน และสารประกอบมัธยันตร์ของมัน
BR0215070A (pt) Métodos de tratamento de infecções bacterianas em cães e gatos
CA3242451A1 (fr) Composition pharmaceutique injectable pour le traitement de maladies respiratoires chez des animaux
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
TH82492A (fr)